ADAP Advocacy, as part of its 340B Project, released a new infographic on the 340B Drug Pricing Program on October 15, 2026. The infographic reinforces the central message of the policy paper and commercial released earlier this year under the same name: ‘340B PROGRAM: The Glue That Should Hold Our Healthcare System Together.’ This release matters because it draws attention to a growing disconnect between the 340B program’s expansion and its intended benefits for vulnerable patients.
Congress created the 340B Drug Pricing Program to extend federal resources and improve patient care. The Affordable Care Act added requirements for hospitals to provide free care and financial aid to poor patients, also known as charity care. What’s particularly striking is that charity care continues to decline year after year. 340B drug purchases rose above $100 billion in 2025 across over 42,000 covered entities and over 32,000 pharmacies. The infographic connects the dots on the program’s unfettered growth and how that growth is failing to deliver on the program’s progress.
The infographic continues ADAP Advocacy’s ‘340B Too Big To Fail‘ national advocacy campaign, highlighting hospitals’ declining charity, rising healthcare executive compensation, and exploding patient medical debt, among other issues. These trends raise questions about whether the program is meeting its original goals and whether federal resources are being used effectively to support patient care.
The infographic can be downloaded online here: https://tinyurl.com/y6asjaw2. The implications of this announcement extend to policymakers, healthcare providers, and patients, as the 340B program’s role in the healthcare system continues to be debated. ADAP Advocacy’s work aims to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improve access to care for persons living with HIV/AIDS. By working with advocates, community, health care, government, patients, pharmaceutical companies, and other stakeholders, ADAP Advocacy seeks to raise awareness, offer patient educational programs, and foster greater community collaboration.
